(Q46818258)

25 December 2017

title

Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions (English)

1 reference

25 December 2017

1

Gladys E Granero

1 reference

25 December 2017

author name string

Chandrasekharan Ramachandran

series ordinal

2

1 reference

25 December 2017

Gordon L Amidon

series ordinal

3

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

25 December 2017

Drug Development and Industrial Pharmacy

published in

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

9

1 reference

25 December 2017

page(s)

917-922

1 reference

25 December 2017

Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Mechanisms of Surfactant Effects on Drug Absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Micronized fenofibrate: a new fibric acid hypolipidemic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Wetting properties of bile salt solutions and dissolution media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

The role of surfactants in the release of very slightly soluble drugs from tablets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Analysis of conjugated and unconjugated bile acids in serum and jejunal fluid of normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03639040500272108

10.1080/03639040500272108

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017